IBBQInvesco Nasdaq Biotechnology ETF
Grow my money#989 of 2944 for Grow my money
Seeks to track the investment results of the Nasdaq Biotechnology Index.
Invesco · Since 2021 (4 years)
Annual Cost
0.19%
#793 out of 5,332 ETFs
Fund Size
$70M
#3054 out of 5,332 ETFs
Dividend Yield
0.87%
Track Record
4 years
#2451 out of 5,332 ETFs
Performance
1 Year
+37.0%
3 Years
+12.7%
5 Years
N/A
What's inside
Asset class
Region
Focus
Biotech & Genomics
Asset allocation
Stocks
100.0%
Cash
0.0%
Sector breakdown
Healthcare
100.0%
Top holdings
Gilead Sciences IncGILD7.7%
Amgen IncAMGN7.5%
Vertex Pharmaceuticals IncVRTX7.4%
Regeneron Pharmaceuticals IncREGN6.5%
Alnylam Pharmaceuticals IncALNY3.5%
Insmed IncINSM2.8%
Biogen IncBIIB2.2%
United Therapeutics CorpUTHR2.1%
argenx SE ADRARGX1.7%
Royalty Pharma PLC Class ARPRX1.7%
Risk profile
Volatility (1Y)
21.0%
High
Max drawdown
-37.9%
Worst peak-to-trough loss
Sharpe (3Y)
0.53
Decent risk-adjusted returns
Sortino (3Y)
0.76
Moderate downside risk
Similar ETFs
Data updated on 2026-05-05